Huntington Begins Coverage on National Health Investors (NYSE:NHI)

Stock analysts at Huntington assumed coverage on shares of National Health Investors (NYSE:NHI) in a report issued on Monday, Zacks reports. The brokerage set a “strong-buy” rating on the real estate investment trust’s stock.

A number of other equities analysts have also recently commented on NHI. National Bank Financial set a $79.00 target price on shares of National Health Investors in a research report on Wednesday, September 9th. Zacks Research upgraded shares of National Health Investors from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 29th. Weiss Ratings downgraded shares of National Health Investors from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, September 25th. Truist Financial lowered their price target on shares of National Health Investors from $81.00 to $80.00 and set a “buy” rating for the company in a report on Wednesday, September 2nd. Finally, Wells Fargo & Company cut their price target on shares of National Health Investors from $78.00 to $68.00 and set an “equal weight” rating on the stock in a report on Monday, October 19th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $81.00.

National Health Investors Stock Down 4.6%

Shares of NYSE NHI opened at $67.96 on Monday. National Health Investors has a one year low of $63.51 and a one year high of $91.38. The company has a debt-to-equity ratio of 0.81, a current ratio of 6.78 and a quick ratio of 6.78. The firm’s 50 day simple moving average is $67.74 and its two-hundred day simple moving average is $76.08. The stock has a market capitalization of $3.34 billion, a P/E ratio of 4.77, a PEG ratio of 4.54 and a beta of 0.51.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Monday, November 9th. The real estate investment trust reported $11.47 earnings per share for the quarter, topping analysts’ consensus estimates of $1.18 by $10.29. National Health Investors had a net margin of 152.82% and a return on equity of 45.12%. The firm had revenue of $113.48 million during the quarter, compared to analyst estimates of $68.53 million. As a group, analysts expect that National Health Investors will post 4.76 EPS for the current fiscal year.

Institutional Trading of National Health Investors

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. purchased a new position in National Health Investors during the 2nd quarter valued at $665,997,000. Bank of New York Mellon Corp purchased a new stake in shares of National Health Investors in the 2nd quarter worth about $122,509,000. Bank of America Corp DE bought a new stake in shares of National Health Investors during the 2nd quarter valued at about $77,738,000. Legal & General Group Plc bought a new stake in shares of National Health Investors during the 2nd quarter valued at about $21,745,000. Finally, Sumitomo Mitsui Trust Group Inc. boosted its stake in shares of National Health Investors by 374.8% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 239,542 shares of the real estate investment trust’s stock valued at $15,721,000 after purchasing an additional 189,096 shares in the last quarter. Hedge funds and other institutional investors own 62.51% of the company’s stock.

National Health Investors News Summary

Here are the key news stories impacting National Health Investors this week:

• Positive Sentiment: NHI outlined a target for high-single-digit to low-double-digit organic same-store senior housing operating portfolio (SHOP) NOI growth, signaling potential operating growth. Article: NHI outlines 2026 guidance and SHOP growth target
• Positive Sentiment: NHI declared a quarterly dividend of $0.94 per share, a potentially supportive feature for income-focused investors. Article: National Health Investors declares dividend
• Negative Sentiment: Third-quarter FFO was $1.12 per share, down from $1.32 a year earlier and below Zacks’ $1.17 consensus estimate, though it matched FactSet’s estimate. That decline may concern investors focused on recurring REIT performance. Article: National Health Investors misses Q3 FFO and revenue estimates
• Negative Sentiment: Full-year 2026 normalized FFO guidance of $4.68–$4.70 per share is below the cited analyst consensus of $4.76, creating a modest earnings-expectations headwind. Article: NHI outlines 2026 guidance
• Negative Sentiment: Operating partners are dealing with community transitions and a muted summer selling season, which could weigh on near-term occupancy, operations, or transaction activity. Article: NHI operating partners face transitions and muted selling season

About National Health Investors

National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust that owns and finances properties used for senior housing and health care. Founded in 1991, the company is headquartered in Murfreesboro, Tennessee. NHI’s portfolio includes senior housing communities, such as independent living, assisted living and memory care properties, as well as skilled nursing facilities. It typically works with health care operators through property leases and mortgage loans. The company serves markets across the United States.